anonymous
Guest
anonymous
Guest
RaQualia is now Phase 3. Approval in the next quarter
Pipeline | RaQualia Pharma Inc.
Licensed Territory: Worldwide Excluding Japan
Pre-Clinical
P1
P2
P3
ApplicatiApproval
Phase 3 Ongoing: U.S.
Partnered Party: HK inno.N Corporation
Licensed Territory: Worldwide Excluding Japan
Pre-Clinical
P1
P2
P3
ApplicatiApproval
Phase 1 Completed: Japan
Partnering Activity Underway
Pipeline | RaQualia Pharma Inc.
Licensed Territory: Worldwide Excluding Japan
Pre-Clinical
P1
P2
P3
ApplicatiApproval
Phase 3 Ongoing: U.S.
Partnered Party: HK inno.N Corporation
Licensed Territory: Worldwide Excluding Japan
Pre-Clinical
P1
P2
P3
ApplicatiApproval
Phase 1 Completed: Japan
Partnering Activity Underway